(RTTNews) - Synergy Pharmaceuticals Inc.'s (SGYP) shares declined around 85 percent in the extended trading on Tuesday after the company confirmed Bausch Health Companies Inc. (BHC, BHC.TO) as the ...

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is having a relatively strong day in the market today, and for good reason. The company released new data with regard to Plecanatide, its lead candidate.

Synergy House Berhad (KLSE:SYNERGY) has had a rough three months with its share price down 18%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals ...

Does Synergy Pharmaceuticals Inc (NASDAQ:SGYP) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the company. Hedge fund firms constantly search ...

Synergy Resources (SYRG) surged Monday after Stifel Nicolaus upgraded the stock to "buy" from "hold" and maintained its $13 price target. The firm cited the company's strong performance and noted ...

What: Shares of Synergy Pharmaceuticals climbed by nearly 19% today on tremendous volume after the company reported that its lead experimental drug,plecanatide, met its primary endpoint in a second ...